Literature DB >> 11848397

6xHis promotes binding of a recombinant protein to heparan sulfate.

H Marie Lacy1, Ralph D Sanderson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11848397     DOI: 10.2144/02322bm04

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


× No keyword cloud information.
  6 in total

1.  The major determinant of the heparin binding of glial cell-line-derived neurotrophic factor is near the N-terminus and is dispensable for receptor binding.

Authors:  Ivan Alfano; Parvez Vora; Rosemary S Mummery; Barbara Mulloy; Christopher C Rider
Journal:  Biochem J       Date:  2007-05-15       Impact factor: 3.857

2.  Enhanced cell-permeant Cre protein for site-specific recombination in cultured cells.

Authors:  Qing Lin; Daewoong Jo; Kassatihun D Gebre-Amlak; H Earl Ruley
Journal:  BMC Biotechnol       Date:  2004-10-22       Impact factor: 2.563

3.  Granulin-epithelin precursor interacts with heparan sulfate on liver cancer cells.

Authors:  Chi Wai Yip; Phyllis F Y Cheung; Idy C Y Leung; Nicholas C L Wong; Christine K C Cheng; Sheung Tat Fan; Siu Tim Cheung
Journal:  Carcinogenesis       Date:  2014-08-12       Impact factor: 4.944

4.  Spatial and temporal expression of heparan sulfate in mouse development regulates FGF and FGF receptor assembly.

Authors:  Benjamin L Allen; Alan C Rapraeger
Journal:  J Cell Biol       Date:  2003-11-10       Impact factor: 10.539

5.  Biologically active fibroblast growth factor 1 tagged with various epitopes.

Authors:  Masahiro Asada; Emi Honda; Toru Imamura
Journal:  BMC Res Notes       Date:  2008-07-11

6.  Membrane permeabilizing amphiphilic peptide delivers recombinant transcription factor and CRISPR-Cas9/Cpf1 ribonucleoproteins in hard-to-modify cells.

Authors:  Thomas Del'Guidice; Jean-Pascal Lepetit-Stoffaes; Louis-Jean Bordeleau; Joannie Roberge; Vanessa Théberge; Coraline Lauvaux; Xavier Barbeau; Jessica Trottier; Vibhuti Dave; Denis-Claude Roy; Bruno Gaillet; Alain Garnier; David Guay
Journal:  PLoS One       Date:  2018-04-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.